Atypical Chemokine Receptor 2 (ACKR2) Antibody

Este producto es parte de ACKR - Atypical chemokine receptor
Product Graph
364€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Atypical Chemokine Receptor 2 (ACKR2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx231341
tested applications
ELISA, IHC

Description

CCBP2 Antibody is a Rabbit Polyclonal against CCBP2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Atypical Chemokine Receptor 2 (ACKR2)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
IHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
≥ 95% (SDS-PAGE)
Purification
Purified by immunogen affinity chromatography.
Size 1
100 µg
Form
Liquid
Tested Applications
ELISA, IHC
Buffer
PBS, pH 7.3, with 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-12 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O00590
Alias
CCBP2,CCR10,CCR9,CMKBR9,D6
Background
Antibody anti-ACKR2
Status
RUO
Note
Concentration: 2 mg/ml - Validity: 12 months.

Descripción

ACKR2 is a non-classical chemokine receptor that functions as a decoy and scavenger receptor, specifically binding pro-inflammatory CC chemokines to modulate immune responses and resolve inflammation. Unlike signaling chemokine receptors, ACKR2 does not trigger intracellular signaling but instead internalizes and degrades its ligands, reducing chemokine availability and dampening inflammation. It is primarily expressed on lymphatic endothelial cells and plays a critical role in maintaining immune homeostasis by clearing chemokines from tissues and promoting the resolution of inflammation. ACKR2 is also involved in shaping chemokine gradients, ensuring proper immune cell trafficking and preventing chronic inflammatory conditions. Dysregulation of ACKR2 has been linked to autoimmune diseases, chronic inflammation, and cancer, where its altered expression may contribute to pathological immune cell infiltration and tumor progression. Its scavenging activity and role in regulating immune responses make ACKR2 a potential therapeutic target for inflammatory and immune-related diseases.

Related Products

FNab01341

ACKR2 antibody

Ver Producto
P2105

Recombinant Human ACKR2

Ver Producto
abx015224

Atypical Chemokine Receptor 2 (ACKR2) Antibody

Rabbit polyclonal antibody against CCBP2 protein. Immunogen region is C-terminal.

Ver Producto